SPIRITT Research Becomes Latest CRO to Join MedNet Solutions' iMedNet Partner Program
SPIRITT Selects iMedNet EDC for its eClinical Flexibility and Ease of Use
MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, is pleased to announce that SPIRITT Research, a boutique research services organization with a passion for improving patient treatment outcomes and quality of life, has joined MedNet’s iMedNet Partner Program. SPIRITT will leverage iMedNet EDC, MedNet’s flagship eClinical solution, to get their research studies set up quickly, easily and cost-effectively.
“SPIRITT is an ideal partner for MedNet, given our companies’ deep, shared expertise supporting orthopedic and spine related research, as well as post market studies and registries,” remarked John M. (Rob) Robertson, President and CEO of MedNet Solutions. “We’re confident that our organizations will work very well together and that iMedNet EDC will provide SPIRITT with the technology infrastructure they need to facilitate effective and efficient research.”
“We are very pleased to be partnering with MedNet Solutions,” commented Francine Schranck, President of SPIRITT. “The iMedNet product is one of the best clinical trial management systems we’ve seen, and we recommend it without reservation.”
Matthew Britt, Director of Clinical Affairs at SPIRITT, added, “We are asked all the time by our clients about the best solutions to support them in their various clinical trials, and because of its flexibility and ease of use, iMedNet is a logical choice.”
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
